InvestorsHub Logo
Followers 31
Posts 3105
Boards Moderated 1
Alias Born 11/20/2017

Re: None

Tuesday, 11/16/2021 10:02:01 AM

Tuesday, November 16, 2021 10:02:01 AM

Post# of 194929
This is a tough situation, because I honestly believe the price is not going to do anything if we stay on the OTC. Might see the occasional spike/run, but that's it. We're at 3 cents even after five years. How should we expect the price to ever maintain a higher price? Only way to do that is to keep growing the business and NOT dilute anymore, while also reducing the share count at some point. That will take years. Even then, no guarantees. Iliad has a lot of shares coming due in 2022, so if we're still on the OTC then, price is going to keep drifting further down for those conversions.

NASDAQ is the better hope, imo, and the benefits of the capital raise cannot be ignored in helping to eliminate the existing debt while also funding the company's strategic, expansive ventures. That's why you go public. To raise stock to grow and expand and this would do so in a non-toxic manner. Also, they're at least showing signs of profitability now. That's huge and something we've been asking for.

The PROBLEM though is they failed to bring any excitement here. An uplist after a year and a half with no signs of an M&A involved is also a let down. A new, charismatic CEO, at a minimum, would go a long way here. If you have investors thinking OTC is a better option right now than NASDAQ, you have a serious issue to address.

Don't miss the big run by always trying to chase the next big run

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News